NYT > Top StoriesAn independent group of experts expressed concerns that the data from clinical trials did not outweigh risks for treatment of post-traumatic stress disorder.
last news of the week
FDA Panel Rejects Use of MDMA for Treatment of PTSD
NYT > Top StoriesAn independent group of experts expressed concerns that the data from clinical trials did not outweigh risks for treatment of post-traumatic stress disorder.
NYT > Top StoriesAn independent group of experts expressed concerns that the data from clinical trials did not outweigh risks for treatment of post-traumatic stress disorder.